Frontlight ResearchEarly access
Acute myeloid leukaemia trials in United States
334 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 1/2Taking peopleStudy to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
- Where
- Atlanta, Bethesda, Indianapolis, Omaha, Philadelphia
- Age
- 18 years and over
- People
- 250 worldwide
- Run by
- CellCentric Ltd.
See details and how to joinNCT04068597 - Phase 2Taking peopleIDH Targeted/Non- Targeted vs Non-targeted/IDH-targeted Approaches in the Treatment of Newly Diagnosed IDH Mutated AML Patients Not Candidates for Intensive Induction Therapy (I- DATA Study)
- Where
- Aurora, Chapel Hill, Columbus, Dallas
- Age
- 18 years and over
- People
- 125
- Run by
- Alice Mims
See details and how to joinNCT05401097 - Phase 1Taking peopleTrial for Patients w/ Advanced Hematologic Malignancies Undergoing Allogeneic HCT
- Where
- Palo Alto
- Age
- 18 years to 70 years
- People
- 24
- Run by
- Stanford University
See details and how to joinNCT06551584 - Phase 1/2Taking people211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute Leukemia
- Where
- Seattle
- Age
- 18 years to 75 years
- People
- 75
- Run by
- Fred Hutchinson Cancer Center
See details and how to joinNCT03128034 - Phase 1/2Taking people211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome
- Where
- Seattle
- Age
- 18 years to 75 years
- People
- 30
- Run by
- Fred Hutchinson Cancer Center
See details and how to joinNCT03670966 - No phaseTaking peopleFamilial Investigations of Childhood Cancer Predisposition
- Where
- Memphis
- People
- 1,500
- Run by
- St. Jude Children's Research Hospital
See details and how to joinNCT03050268 - Phase 1Taking peopleSL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
- Where
- Boston, Duarte, Houston
- Age
- 18 years and over
- People
- 72
- Run by
- Dana-Farber Cancer Institute
See details and how to joinNCT03113643 - Phase 1Taking peopleA Phase 1 Trial of CIML NK Cell Infusion for Myeloid Disease Relapse After Hematopoietic Cell Transplantation
- Where
- Boston
- Age
- 12 years and over
- People
- 50
- Run by
- Dana-Farber Cancer Institute
See details and how to joinNCT04024761 - Phase 1Taking peoplePreemptive CIML NK Cell Therapy After Hematopoietic Stem Cell Transplantation
- Where
- Boston
- Age
- 18 years and over
- People
- 15
- Run by
- Dana-Farber Cancer Institute
See details and how to joinNCT06138587 - Phase 1Taking peopleA Study of Natural Killer Cells in Combination With Atezolizumab in People With Acute Myelogenous Leukemia
- Where
- Basking Ridge, Commack, Harrison, Middletown, Montvale, New York, Rockville Centre
- Age
- 18 years to 70 years
- People
- 18
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT07011004 - Phase 1Taking peopleStudy of Orally Administered AG-120 in Subjects With Advanced Hematologic Malignancies With an IDH1 Mutation
- Where
- Atlanta, Aurora, Baltimore, Birmingham, Boston, Charleston, Chicago, Cleveland, Columbus, Dallas, Detroit, Duarte, Durham, Houston, Jacksonville, Los Angeles, Miami, Nashville, New York, Phoenix, Portland, San Francisco, St Louis, Tampa
- Age
- 18 years and over
- People
- 291 worldwide
- Run by
- Institut de Recherches Internationales Servier
See details and how to joinNCT02074839 - Phase 1Taking peopleBAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia
- Where
- Ann Arbor, Atlanta, Coral Gables, Dallas, Houston, New Haven, New York, Portland, The Bronx
- Age
- 18 years and over
- People
- 260 worldwide
- Run by
- SillaJen, Inc.
See details and how to joinNCT05768932 - Phase 1/2Taking peopleCladribine, Idarubicin, Cytarabine, and Quizartinib in Treating Patients With Newly Diagnosed, Relapsed, or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
- Where
- Houston
- Age
- 18 years and over
- People
- 80
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT04047641 - Phase 1Taking peopleA Phase Ib Trial of Azacitidine, Venetoclax and Allogeneic NK Cells for Acute Myeloid Leukemia (ADVENT-AML)
- Where
- Cleveland, Houston
- Age
- 18 years and over
- People
- 32
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT05834244 - Phase 1Taking peopleA Phase I Study Investigating the Combination of the Menin Inhibitor Ziftomenib With Venetoclax and Gemtuzumab in Pediatric Patients With Acute Myeloid Leukemia
- Where
- Houston
- Age
- 3 years to 21 years
- People
- 22
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT06448013 - Phase 1Taking peopleA Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma
- Where
- Rochester, Scottsdale
- Age
- 18 years and over
- People
- 99
- Run by
- Mayo Clinic
See details and how to joinNCT03017820 - Phase 2Taking peopleAlpha/Beta T Cell and CD19+ B Cell Depletion in Allogeneic Stem Cell Transplantation in Patients With Malignant Diseases
- Where
- Gainesville
- Age
- 6 months to 39 years
- People
- 20
- Run by
- University of Florida
See details and how to joinNCT05800210 - No phaseTaking peopleCharacterization of T-cell Repertoire in Patients With Acute Myeloid Leukemia Undergoing Donor Stem Cell Transplant
- Where
- Los Angeles
- Age
- 18 years and over
- People
- 250
- Run by
- University of Southern California
See details and how to joinNCT03921047 - Early phase 1Taking peopleHyperbaric Oxygen Therapy and Allogeneic Peripheral Blood Stem Cell (PBSC) Transplant
- Where
- Rochester
- Age
- 18 years to 75 years
- People
- 24
- Run by
- Omar Aljitawi
See details and how to joinNCT03964506 - Phase 2Taking peopleDonor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies
- Where
- Seattle
- Age
- 6 months and over
- People
- 60
- Run by
- Fred Hutchinson Cancer Center
See details and how to joinNCT04195633 - Phase 1Taking peopleStudy to Evaluate the Pharmacokinetics and Safety of Oral Decitabine and Cedazuridine in Cancer Patients With Renal Impairment
- Where
- Houston
- Age
- 18 years and over
- People
- 18 worldwide
- Run by
- Taiho Oncology, Inc.
See details and how to joinNCT04953897 · EU 2024-516291-16-00 - Phase 1Taking peopleStudy to Evaluate the Pharmacokinetics and Safety of Oral Decitabine and Cedazuridine in Cancer Patients With Hepatic Impairment
- Where
- Houston
- Age
- 18 years and over
- People
- 27 worldwide
- Run by
- Taiho Oncology, Inc.
See details and how to joinNCT04953910 · EU 2024-516292-33-00 - Phase 1Taking peopleCD123-Directed T-Cell Therapy for Acute Myelogenous Leukemia (CATCHAML)
- Where
- Memphis
- Age
- Up to 21 years
- People
- 108
- Run by
- St. Jude Children's Research Hospital
See details and how to joinNCT04318678 - Phase 1/2Taking peopleAdapt NK for High Risk Myeloid Diseases as Bridge to Allo HSCT
- Where
- Minneapolis
- Age
- 18 years and over
- People
- 18
- Run by
- Masonic Cancer Center, University of Minnesota
See details and how to joinNCT07591649 - Phase 1Taking peopleHA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
- Where
- Seattle
- Age
- Up to 80 years
- People
- 24
- Run by
- Fred Hutchinson Cancer Center
See details and how to joinNCT03326921